JPS63123398A - Production of l-alpha-methylphenylalanines - Google Patents
Production of l-alpha-methylphenylalaninesInfo
- Publication number
- JPS63123398A JPS63123398A JP26676086A JP26676086A JPS63123398A JP S63123398 A JPS63123398 A JP S63123398A JP 26676086 A JP26676086 A JP 26676086A JP 26676086 A JP26676086 A JP 26676086A JP S63123398 A JPS63123398 A JP S63123398A
- Authority
- JP
- Japan
- Prior art keywords
- methylphenylalanine
- medium
- methylphenylalaninamide
- alpha
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 241000186359 Mycobacterium Species 0.000 claims abstract description 18
- HYOWVAAEQCNGLE-JTQLQIEISA-N alpha-methyl-L-phenylalanine Chemical compound OC(=O)[C@](N)(C)CC1=CC=CC=C1 HYOWVAAEQCNGLE-JTQLQIEISA-N 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- -1 DL-α-methylphenylalanine amides Chemical class 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 230000001580 bacterial effect Effects 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- 239000000758 substrate Substances 0.000 description 16
- 229920001817 Agar Polymers 0.000 description 14
- 239000008272 agar Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- LEBDCRNSLNAHHD-JTQLQIEISA-N (2s)-2-amino-2-methyl-3-phenylpropanamide Chemical compound NC(=O)[C@](N)(C)CC1=CC=CC=C1 LEBDCRNSLNAHHD-JTQLQIEISA-N 0.000 description 3
- 108700023418 Amidases Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- SCIFESDRCALIIM-VIFPVBQESA-N N-methyl-L-phenylalanine Chemical class C[NH2+][C@H](C([O-])=O)CC1=CC=CC=C1 SCIFESDRCALIIM-VIFPVBQESA-N 0.000 description 3
- 102000005922 amidase Human genes 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- HYOWVAAEQCNGLE-SNVBAGLBSA-N (2r)-2-azaniumyl-2-methyl-3-phenylpropanoate Chemical compound [O-]C(=O)[C@@]([NH3+])(C)CC1=CC=CC=C1 HYOWVAAEQCNGLE-SNVBAGLBSA-N 0.000 description 2
- KUHHQKOJDDCWIB-NSHDSACASA-N (2s)-2-amino-3-(1,3-benzodioxol-5-yl)-2-methylpropanoic acid Chemical compound OC(=O)[C@](N)(C)CC1=CC=C2OCOC2=C1 KUHHQKOJDDCWIB-NSHDSACASA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000015784 hyperosmotic salinity response Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- SCIFESDRCALIIM-UHFFFAOYSA-N n-methylphenylalanine Chemical compound CNC(C(O)=O)CC1=CC=CC=C1 SCIFESDRCALIIM-UHFFFAOYSA-N 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 241000282596 Hylobatidae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241000600169 Maro Species 0.000 description 1
- 229910018890 NaMoO4 Inorganic materials 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HYOWVAAEQCNGLE-UHFFFAOYSA-N alpha-Methylphenylalanine Chemical compound OC(=O)C(N)(C)CC1=CC=CC=C1 HYOWVAAEQCNGLE-UHFFFAOYSA-N 0.000 description 1
- 229940113720 aminosalicylate Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002751 molybdenum Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、新M種であるミコバクテリウムメタ/リカを
使用し、DL−α−メチルフェニルアラニンアミド類か
らこれに対応するL−α−メチルフェニルアラニン類を
製造する方法に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention uses Mycobacterium meta/rica, a new M species, to obtain the corresponding L-α- The present invention relates to a method for producing methylphenylalanines.
α−メチルフェニルアラニン類のL一体は、薬理作用を
有しており、その代表的なものとして、L−3,4−ジ
ヒドロキシ−α−メチルフェニルアラニンが知られてい
る。この物質は、一般名としてL−α−メチルドーパと
称され、優れた血圧降下剤であり、L−α−メチルフェ
ニルアラニン類はその原料物質である。L-units of α-methylphenylalanines have pharmacological effects, and L-3,4-dihydroxy-α-methylphenylalanine is known as a typical example thereof. This substance, commonly referred to as L-α-methyldopa, is an excellent antihypertensive agent, and L-α-methylphenylalanines are its raw materials.
〔従来技術、発明が解決しようとする問題点〕従来、L
−α−メチルフェニルアラニン類ノ製造方法として、α
−メチルフェニルアラニン類のラセミ体を光学分割する
方法として、ジアステレオマー法あるいは直接晶析法に
よる物理的方法および微生物を利用する生化学方法が検
討されてきた。しかしながら、これらのいずれの方法も
収率が低いなどの理由により製造コストが高くなり工業
的プロセスとしては不十分なものである、
一方、近年、DL−α−メチルフェニルアラニンアミド
類を基質として、これに微生物の生産するアミダーゼを
作用させ、L−α−メチルフェニルアラニン類を得る方
法が知られている(特開昭57−11116495号公
報)。しかしながら、この方法では、用いられる微生物
菌体の活性は、工業的生産に使用できる程十分に高くは
ない。[Prior art, problems to be solved by the invention] Conventionally, L
-As a method for producing α-methylphenylalanine, α
- Physical methods using diastereomer methods or direct crystallization methods and biochemical methods using microorganisms have been investigated as methods for optically resolving racemic forms of methylphenylalanines. However, all of these methods are unsatisfactory as industrial processes due to high production costs due to low yields.On the other hand, in recent years, DL-α-methylphenylalanine amides have been used as substrates. A method is known in which L-α-methylphenylalanines are obtained by allowing amidase produced by microorganisms to act on L-α-methylphenylalanines (JP-A-57-11116495). However, in this method, the activity of the microorganism used is not high enough to be used for industrial production.
本発明者らは、DL−α−メチルフェニルアラニンアミ
ド類を基質として、効率よくL−α−メチルフェニルア
ラニン類に転換する微生物を自然界よりスクリーニング
したところ、その目的に適する菌株を得ることが出来、
この菌株を使用する本発明を完成した。この菌株は、ミ
コバクテリウム属に属する菌株であるが、その菌学的性
質から新菌種であると判断され、これをミコバクテリウ
ム メタノリカと命名した。The present inventors screened the natural world for microorganisms that efficiently convert DL-α-methylphenylalanine amides into L-α-methylphenylalanines as a substrate, and were able to obtain a strain suitable for that purpose.
The present invention using this strain was completed. Although this strain belongs to the genus Mycobacterium, it was determined to be a new bacterial species based on its mycological properties, and was named Mycobacterium methanolica.
すなわち、本発明は、
一般式 ■
(ただし、式中R1、R2は互いに同一または異なって
、水素原子、低級アルキル基であるかまたはR′とR2
はアルキレン基であって、互いに結合し、5〜8員環を
形成することもできる。)
で表わされるD L−α−メチルフェニルアラニンアミ
ド類に、ミコバクテリウム メタノリカの菌体またはそ
の処理物を作用させてL−α−メチルフェニルアラニン
アミド類−を不斉加水分解して
一般式 1
(ただし、式中RおよびR2は前記一般式+におけると
同様である)
で表わされるL−α−メチルフェニルアラニン類を得る
ことを特徴とするL−α−メチルフェニルアラニン類の
製造法である。That is, the present invention is based on the general formula (1) (wherein R1 and R2 are the same or different and are a hydrogen atom, a lower alkyl group, or
are alkylene groups, and can also be bonded to each other to form a 5- to 8-membered ring. ) The L-α-methylphenylalanine amides represented by the general formula 1 ( However, in the formula, R and R2 are the same as in the general formula +.
本発明における基質である前記一般式■で表わされるD
L−α−メチルフェニルアラニンアミド類の代表例を挙
げるが、本発明の基質はこれらに限定されるものではな
い。D represented by the general formula (2), which is a substrate in the present invention
Representative examples of L-α-methylphenylalanine amides are listed below, but the substrates of the present invention are not limited thereto.
DL−3,4−ジヒドロキシ−α−
メチルフェニルアラニンアミド
H2
DL−4−ヒドロキシ−3−メトキ
シ−α−メチルフェニルアラニンア
ミド
H2
DL−5,4−ジメトキシ−α−メ
チルフェニルアラニンアミド
NH2
DL−3,4−メチレンジオキシ
一α−メチルフェニルアラニンア
ミド
微生物によってこれらの基質を不斉加水分解して、それ
ぞれの基質に対応するL−α−メチルフェニルアラニン
類が得られる。DL-3,4-dihydroxy-α-methylphenylalaninamide H2 DL-4-hydroxy-3-methoxy-α-methylphenylalaninamide H2 DL-5,4-dimethoxy-α-methylphenylalaninamide NH2 DL-3,4- Methylenedioxy-α-methylphenylalanine amide These substrates are asymmetrically hydrolyzed by microorganisms to obtain L-α-methylphenylalanines corresponding to each substrate.
なおL−α−メチルドーパは、これらの基質ノウち、D
L−!1,4−ジヒドロキシーα−メチルフェニルアラ
ニンアミドおよびDT、−5゜4−メチレンジオキシ−
α−メチルフェニルアラニンアミドから得ることができ
る。In addition, L-α-methyldopa is based on these substrates, D
L-! 1,4-dihydroxy-α-methylphenylalaninamide and DT, -5゜4-methylenedioxy-
It can be obtained from α-methylphenylalanine amide.
すなわち、DL−5,4−ジヒドロキシ−αまた、DL
−5,4−メチレンジオキシ−α−メチルフェニルアラ
ニンを基質として用いた場合には本発明により得られた
L−5,4−メチレンジオキシ−α−メチルフェニルア
ラニンのメチレンジオキシ結合を常法に従い=たとえば
フェノールの存在下で塩酸の如き鉱酸にて処理して、加
水分解することにより一容易に、L−3、4−’)ヒド
ロキシ−α−メチルフェニルアラニン(L−α−メチル
ドーパ)を得ることが出来る。That is, DL-5,4-dihydroxy-α and DL
When -5,4-methylenedioxy-α-methylphenylalanine is used as a substrate, the methylenedioxy bond of L-5,4-methylenedioxy-α-methylphenylalanine obtained according to the present invention is removed by a conventional method. =L-3,4-')hydroxy-α-methylphenylalanine (L-α-methyldopa) is easily obtained by hydrolysis, for example by treatment with a mineral acid such as hydrochloric acid in the presence of phenol. I can do it.
本発明に用いられる細菌は、ミコバクテリウム メタノ
リカに属する菌株であれば、いずれの菌株でもよい。The bacteria used in the present invention may be any strain as long as it belongs to Mycobacterium methanolica.
ミコバクテリウム メタノリカは本発明者らが発見1.
た新菌種であるが、この新菌種に属する細菌のうち代表
的な菌株であるミコバクテリウム メタノリカ BT8
4(il工研菌寄第8823号)、同BT−143(微
工研菌寄第8824号)、同P−23(微工研菌寄第8
825号)、同P−26(微工研菌寄第8826号)お
よび同P−85(p1研菌寄第8827号)のそれぞれ
の菌学的性質を示す。Mycobacterium methanolica was discovered by the present inventors 1.
Mycobacterium methanolica BT8 is a representative strain of bacteria belonging to this new bacterial species.
4 (Il Koken Bibori No. 8823), BT-143 (Il Koken Bikyo No. 8824), P-23 (Il Koken Bikki No. 8
825), the same P-26 (P1 Research Institute No. 8826), and the same P-85 (P1 Research Institute No. 8827).
菌学的性質
(1)顕微鏡的形態
肉汁液体培地および肉汁寒天培地で67°Cで3日間培
養した。Mycological Properties (1) Microscopic Morphology Cultured at 67°C for 3 days in broth liquid medium and broth agar medium.
■ 細胞の形状および大きさ
通常は短桿菌。幅0.5〜0.8u、長さ1〜3u0V
型の分裂細胞が認められる。■ Cell shape and size Usually short rods. Width 0.5~0.8u, length 1~3u0V
type of dividing cells are observed.
■ 運動性 なし。■ No motility.
■ 胞子の有無 生産されない。■ Presence or absence of spores: Not produced.
■ グラム染色 グラム陽性 ■ 抗酸性 陽性 (2)各種の培地における生育状態 ■ 肉汁寒天平板培養 37℃で3日間培養。■ Gram staining Gram positive ■ Anti-acidity positive (2) Growth status in various media ■ Broth agar plate culture Cultivate at 37℃ for 3 days.
中程度の生育を示す。Shows medium growth.
コロニーの形状;外形は円形、大きさは2〜3?[、隆
起は半球状、構造は均質、表面は粗面、辺縁は波状、色
は黄白色で光沢なし、透明度は不透明、硬度はバター質
。Colony shape: circular in shape, size 2-3? [, The ridges are hemispherical, the structure is homogeneous, the surface is rough, the edges are wavy, the color is yellowish-white and lack luster, the transparency is opaque, and the hardness is buttery.
■ メタノール含有寒天平板培養 37℃で3日間培養。■Methanol-containing agar plate culture Cultured at 37°C for 3 days.
肉汁寒天平板培養と同じ。Same as broth agar plate culture.
■ 肉汁寒天斜面培養 37℃で3日間培養。■ Meat juice agar slant culture Cultured at 37°C for 3 days.
接種線に一様に中程度な生育を示す。It shows medium growth uniformly along the inoculation line.
隆起は中程度、表面は粗面、辺縁は波状、色は黄白色で
光沢なし、透明度は不透明、硬度はバター質。Medium ridges, rough surface, wavy margins, yellowish-white color with no gloss, opaque transparency, and buttery hardness.
■ メタノール含有寒天斜面培養 37℃で3日間培養。■ Methanol-containing agar slant culture Cultured at 37°C for 3 days.
肉汁寒天斜面培養と同じ。Same as broth agar slant culture.
■ 肉汁液体培養 37℃で6日間培養。■ Meat juice liquid culture Cultivated at 37℃ for 6 days.
白クリーム色の画壇を形成する。また、皮膜を形成する
。Forms a white cream painting platform. It also forms a film.
■ ペプトン水液体培養 37℃で3日間培養。■ Peptone water liquid culture Cultivate at 37℃ for 3 days.
肉汁液体培養と同じ。Same as broth liquid culture.
■ メタノール含有液体培養 37℃で3日間培養。旺盛に生育する。■ Methanol-containing liquid culture Cultured at 37°C for 3 days. Grows vigorously.
白クリーム色の画壇を形成する。また、皮膜を形成する
。Forms a white cream painting platform. It also forms a film.
■ 肉汁ゼラチン穿刺培養 20℃で4週間培養。■ Meat juice gelatin puncture culture Cultured at 20°C for 4 weeks.
生育する。しかし、ゼラチン液化性はない。Grow. However, it does not have gelatin liquefaction properties.
■ リドマスミルク培養 37°Cで4週間培養。■ Lidomus milk culture Cultivate at 37°C for 4 weeks.
生育し、培養液はアルカリに変化(pH688〜pH8
、3)するが、ペプトン化はしない。It grows, and the culture solution changes to alkaline (pH 688 to pH 8).
, 3) but without peptonization.
(’i) 1%小川培地培養 37℃で3日間培養。('i) 1% Ogawa medium culture, cultured at 37°C for 3 days.
旺盛に生育する。集落性状はスムースである。Grows vigorously. The characteristics of the village are smooth.
OHA培地(塩酸ヒドロキシルアミン 5o o ug
7テi添加1係小川培地)培養37℃で5日間培養。OHA medium (hydroxylamine hydrochloride 5 o ug
7Tei supplemented with Ogawa medium) Culture at 37°C for 5 days.
旺盛に生育する。Grows vigorously.
6 PA8培地(パラアミノサリチル酸ナトリウム
2W1ml添加1係小川培地)培養
37℃で7日間培養。6 PA8 medium (sodium para-aminosalicylate
Culture (Ogawa medium supplemented with 1 ml of 2W) at 37°C for 7 days.
旺盛に生育し、培地が黒変する。It grows vigorously and the medium turns black.
P−23株のみ培地の黒変はみられない。Only strain P-23 shows no blackening of the medium.
0 ピクリン酸培地(0,24ピクリン酸添加変法8a
uton寒天培地)培養
37°Cで2週間培養。0 picric acid medium (modified method 8a with addition of 0.24 picric acid)
(UTON agar medium) Culture at 37°C for 2 weeks.
旺盛に生育し、培地が赤褐色となる。It grows vigorously and the medium turns reddish brown.
P−25株のみ培地が赤褐色にならない、OPNB培地
(バラニトロ安息香酸500”I/me添加1チ小川培
地)培養
37℃で7日間培養。Only the P-25 strain did not turn reddish-brown. Cultured in OPNB medium (Ogawa medium supplemented with 500"I/me of balanitrobenzoic acid) at 37°C for 7 days.
旺盛に生育する。Grows vigorously.
(i3 EB培地(エタンブトール5t19/−メ添
加1チ小川培地)培養
37℃で7日間培養。(i3 EB medium (1 t Ogawa medium supplemented with ethambutol 5t19/-) Cultured at 37°C for 7 days.
旺盛に生育する。Grows vigorously.
(3)生理学的性質 ■ 硝酸塩の還元 硝酸塩を亜硝酸塩に還元する。(3) Physiological properties ■ Nitrate reduction Reduces nitrate to nitrite.
■ MRテスト 陰性
■ vpテスト 陰性
■ インドールの生成 陰性
■ 硫化水素の生成 陽性
■ でんぷんの加水分解 陰性
■ 窒素源の利用
アンモニウム塩、硝酸塩、尿素、およびペプトンを窒素
源として利用する。■ MR test negative ■ vp test negative ■ Indole formation negative ■ Hydrogen sulfide formation positive ■ Starch hydrolysis negative ■ Use of nitrogen sources Ammonium salts, nitrates, urea, and peptone are used as nitrogen sources.
■ 色素の生成 生成しない。■ Pigment generation No generation.
■ ウレアーゼ 陽性 0 カタラーゼ 陽性 0 アンモニアの生成 生成する。■ Urease Positive 0 Catalase Positive 0 Production of ammonia Produce.
◎ 脱窒反応 陰性 0 オキシダーゼ反応 陰性 00−Fテスト 陰性 0 生育の範囲 pH5〜9の範囲で生育する。pH6〜8が好ましい。◎ Denitrification reaction Negative 0 Oxidase reaction Negative 00-F test Negative 0 Growth range It grows in the pH range of 5 to 9. pH 6-8 is preferred.
5℃、43℃で生育しない。25〜40℃が好ましい。It does not grow at 5°C or 43°C. 25-40°C is preferred.
0 酸素に対する態度 好気性0 耐塩性 3重+%NaC1含有培地で旺盛に生育する。0 Attitude towards oxygen Aerobic 0 Salt tolerance Grows vigorously in triplex +% NaCl-containing medium.
6を量% NaC6含有培地で、B’r−84、B’l
”−143株は弱く生育するが、P−23、P−26、
P−85株は生育しない。6 in volume% NaC6-containing medium, B'r-84, B'l
``-143 strain grows weakly, but P-23, P-26,
P-85 strain does not grow.
0 ビタミン要求性 なし
O光発色試験 陰性
■ 暗発色試験 陰性
の ツイーン80水解試験 陰性
0 ミコール酸の含有 陽性
■ GC(グアニン+シトシン)tt
BT−8466、2mo1%
BT−14366、2mo14
P 25 67.2mo1%P−2666、
8mo1%
P−8568、7molcl)
■ 主要な菌体脂肪酸組成物
直鎖脂肪酸 016:0
七ノ不飽和脂肪酸 C14:1 、。、8:。0 Vitamin requirement None O Photochromic test negative ■ Dark color test negative Tween 80 hydrolysis test Negative 0 Contains mycolic acid Positive ■ GC (guanine + cytosine) tt BT-8466, 2mo1% BT-14366, 2mo14 P 25 67. 2mo1%P-2666,
8mol1% P-8568, 7molcl) ■ Main bacterial fatty acid composition Straight chain fatty acid 016:0 Heptanounsaturated fatty acid C14:1. , 8:.
10メチル脂肪酸 10−methyl C19:。10-methyl fatty acid 10-methyl C19:.
■ キノンタイプ メナキ/ン MK 9(Hz)
O細胞壁の構造 me%0− ジアミノピメリン酸
を含有する。■ Quinone type Menaki/N MK 9 (Hz)
Structure of O cell wall me%0- Contains diaminopimelic acid.
0 分離源 土壌
バージイズ マニュアルーオブ デターミネイティブ
バクテリオロジ−(Bergev’s Manu−al
Determinative Bacteriolo
gy)第8版〔編集者 ブツキャナン(Buchana
n)、ギボンズ(Gibbons )、コワン(Cow
an) 、ホルト(Ho r t )、リストン(Li
5ton) 、 ムレ−(Mur−ray)、ニイ
ヴン(Niven)、ラヴイン(Ravin)およびス
タニイア(8tainierCウイリアムズアンド ゥ
イルキンス社(Wi I I iams & Wi 1
−kins)、(197a))cよると、これらの菌株
は、桿菌であり、運動性がなく、ダラム陽性であり、抗
酸性であり、ミコール酸を含有し、好気的であることか
ら、ミコバクテリウム属(Mycobacterium
) に属するものと判断した。0 Separation Source Soil Verges Manual of Determinative
Bacteriology (Bergev's Manu-al
Determinative Bacteriolo
gy) 8th edition [Editor: Buchanan
n), Gibbons, Cow
an), Hort, and Liston.
5 tons), Murray, Niven, Ravin and Stanier (8tainierC)
-kins), (197a)) c, these strains are bacilli, non-motile, Durham positive, acid-fast, contain mycolic acid, and are aerobic. Mycobacterium spp.
).
このことは、GC含量、菌体脂肪酸組成、キノン・タイ
プおよび細胞壁の構造の点からも支持される。This is also supported by the GC content, cell fatty acid composition, quinone type, and cell wall structure.
しかしながら、ミコバクテリウム属に属する公知の菌種
と比較すると、メタノールをはじめとする各々の炭素源
の資化性、炭素化合物からの酸の生成、耐塩性、生育温
度などの点から一致するものは見当たらない。また、ミ
コバクテリウム属に属する細菌でメタノール資化能を有
する細菌は見出されておらず、この新菌種が最初である
。However, when compared with known bacterial species belonging to the genus Mycobacterium, they are similar in terms of ability to assimilate carbon sources including methanol, production of acids from carbon compounds, salt tolerance, growth temperature, etc. is not found. Furthermore, no bacteria belonging to the genus Mycobacterium that has the ability to assimilate methanol have been found, and this new bacterial species is the first.
実験方法は前記のバージイス マニュアルおよび医科学
研究所学友会編「細菌学実習提要」(195B)に従っ
た。The experimental method was in accordance with the above-mentioned Burgeis manual and ``Bacteriology Practice Summary'' (195B) edited by the Institute of Medical Science Alumni Association.
また、メタ/−ル含有岑天平板培地、メタノール含有寒
天斜面培地として次の組成のものを使用した。すなわち
、(NT(4)2804 3.fil、KH2PO41
,4g、NazHPO42、19、Mg804−7’H
2O0,29、CaC1z・2Hz030111F、F
eC6H5O?・xH2O30ダ、 MnCl2 ・4
H205#、Zn804・7H205W9、CuSO4
・5H200、5nG+おヨヒテイフコ(Dirco)
社製寒天(バクトアガー Bacto−agar)15
gを純水11に溶解し、これをpH7,1に調整しIK
47cmtQで20分間殺菌したのち、メタノール 1
0gを無菌的に添加し、平板培地あるいは斜面培地を作
成し、また、メタ/−ル含有液体培地としては、前記の
培地において、寒天を添加しないものを用いた。In addition, the following compositions were used as a methanol-containing agar plate medium and a methanol-containing agar slant medium. That is, (NT(4)2804 3.fil, KH2PO41
,4g, NazHPO42,19, Mg804-7'H
2O0,29,CaC1z・2Hz030111F,F
eC6H5O?・xH2O30 da, MnCl2 ・4
H205#, Zn804/7H205W9, CuSO4
・5H200, 5nG + Oyohiteifuko (Dirco)
Bacto-agar 15
Dissolve g in pure water 11, adjust this to pH 7.1 and IK
After sterilizing with 47cmtQ for 20 minutes, methanol 1
0 g was added aseptically to prepare a plate culture medium or a slant culture medium.The above-mentioned medium without agar was used as the liquid medium containing methanol.
分離源である土壌からのこの新菌種に属する細菌の分離
は、前記のメタ/−ル含有寒天平板培地を用いて常法で
行った。Bacteria belonging to this new bacterial species were isolated from the soil, which was the source of isolation, in a conventional manner using the agar plate medium containing metal/alcohol as described above.
本細菌(本発明で使用される細菌、以下同様)の培養に
使用する培地は、本細菌が資化しうる炭素源を少なくと
も含有していることを要し、さらに適量の窒素源および
無機塩などを含有する培地ならば合成培地および天然培
地のどちらでもよい。The medium used for culturing this bacterium (the bacterium used in the present invention, hereinafter the same) must contain at least a carbon source that can be assimilated by this bacterium, and an appropriate amount of nitrogen source and inorganic salts. Either a synthetic medium or a natural medium may be used as long as the medium contains the following.
炭素源としては、本細菌が資化しうる炭素源であれば特
に制限はなく、たとえばメタノール、エタノールなどの
アルコール類、グルコース。The carbon source is not particularly limited as long as it can be assimilated by this bacterium, such as alcohols such as methanol and ethanol, and glucose.
フラクトース、ソルビトール、グリセリンなどの糖類、
こはく酸などの有機醸、糖蜜、ペプトン、尊母エキスな
どの糖含有物などを用いることが出来る。窒素源として
は、たとえば、アンモニウム塩、硝酸塩などの無機窒素
化合物および/または、たとえば、アミド類、尿素、コ
ーン・ステイープ・リカー、カゼイン、ペプトン、酵母
エキスおよび肉エキスなどの有機窒素化合物が用いられ
る。なお、アミド類としては本発明で基質として使用す
るアミド類が好ましい。sugars such as fructose, sorbitol, and glycerin;
Organic brews such as succinic acid, sugar-containing substances such as molasses, peptone, and extract of sucrose can be used. As nitrogen sources, inorganic nitrogen compounds are used, such as, for example, ammonium salts, nitrates, and/or organic nitrogen compounds, such as, for example, amides, urea, corn steep liquor, casein, peptone, yeast extract and meat extract. . In addition, as the amide, the amide used as a substrate in the present invention is preferable.
また、アミド類は酵素活性の誘導物質として作用するこ
ともある。Amides may also act as inducers of enzyme activity.
また、無機成分としては、たとえば、カルシウム塩、マ
グネシウム塩、カリウム塩、ナトリウム塩、りん酸塩、
マンガン塩、亜鉛塩、鉄塩、銅塩、モリブデン塩、コバ
ルト塩、はう素化合物およびよう素化合物が用いられる
。In addition, examples of inorganic components include calcium salts, magnesium salts, potassium salts, sodium salts, phosphates,
Manganese salts, zinc salts, iron salts, copper salts, molybdenum salts, cobalt salts, boron compounds and iodine compounds are used.
培養条件は、温度20〜42℃、好ましくは25〜40
℃、pHs〜9、好ましくは6〜8である。このような
条件で好気的に培養を行う。The culture conditions are a temperature of 20 to 42°C, preferably 25 to 40°C.
℃, pHs ~9, preferably 6-8. Culture is carried out aerobically under these conditions.
これらの条件をはずれて培養した場合には、本細菌の増
殖は悪くなるが、これらの条件をはずして培養すること
を妨げない。If cultured outside of these conditions, the growth of this bacterium will be impaired, but this does not preclude cultivation under these conditions.
本発明において、ミコバクテリウム メタノリカをDL
−α−メチルフェニルアラニンアミド類に作用させるに
は、液体培地に微生物を培養した培養液、培養液から分
離した菌体、あるいは培養液または菌体から分離した酵
素(アミダーゼ)の粗製酵素、精製酵素、酵素含有抽出
液、またはその濃縮物などの処理物(菌体以外のものを
総括して処理物と記すこともある)などの状態で作用さ
せる。また、菌体および酵素などを担体で固定化して使
用に供することもできる。In the present invention, Mycobacterium methanolica is DL
- In order to act on α-methylphenylalanine amides, use a culture solution obtained by culturing microorganisms in a liquid medium, bacterial cells isolated from the culture solution, or a crude enzyme (amidase) or purified enzyme isolated from the culture solution or bacterial cells. , enzyme-containing extract, or its concentrate (sometimes things other than bacterial cells are collectively referred to as treated products) are used to act. Furthermore, bacterial cells, enzymes, and the like can be immobilized on a carrier for use.
この固定化に使用される担体としては、アルギン酸、カ
ラギーナン、コラーゲン、セルロース、アセチルセルロ
ース、寒天、セロファン、コロジオンなどの天然物、あ
るいはポリアクリルアマイド、ポリスチレン、ポリエチ
レングリコール、ポリプロピレングリコール、ポリウレ
タン、ポリブタジェンなどの高分子物質が挙げられる。The carriers used for this immobilization include natural products such as alginic acid, carrageenan, collagen, cellulose, acetyl cellulose, agar, cellophane, and collodion, or polyacrylamide, polystyrene, polyethylene glycol, polypropylene glycol, polyurethane, and polybutadiene. Examples include polymeric substances.
固定化は、常法によって行なわれるが、アミダーゼ活性
を損うことのない緩和な条件下、で行なう必要がある。Immobilization is carried out by conventional methods, but it must be carried out under mild conditions that do not impair amidase activity.
本発明において、DL−α−メチルフェニルアラニンア
ミド類にミコバクテリウム メタ/リカの菌体またはそ
の処理物を作用させて不斉加水分解する反応条件として
、反応温度は20〜50℃、好ましくは30〜45℃で
あり、反応pHは4〜10、好ましくは7〜9である。In the present invention, the reaction temperature is 20 to 50°C, preferably 30°C, as reaction conditions for asymmetric hydrolysis of DL-α-methylphenylalaninamide by the action of Mycobacterium meta/rica cells or a treated product thereof. ~45°C, and the reaction pH is 4-10, preferably 7-9.
反応時間は、通常は30分間乃至1.5日間で充分であ
り1時間乃至1日間程度が好適である。The reaction time is usually sufficient from 30 minutes to 1.5 days, and preferably about 1 hour to 1 day.
反応温度を高めたり、菌体またはその処理物の使用量を
増加させるなどにより反応時間をより短縮することも可
能である。It is also possible to further shorten the reaction time by raising the reaction temperature, increasing the amount of bacterial cells or their processed material, etc.
本発明において、微生物の使用量は、基質であるDL−
α−メチルフェニルアラニンアミド類に対し、乾燥菌体
として重量比でo、01〜1の範囲内になるように用い
るのが好ましい。In the present invention, the amount of microorganisms used is the substrate DL-
It is preferable to use it so that the weight ratio of dried bacterial cells to α-methylphenylalaninamide is within the range of 01 to 1.
なお、この範囲外とすることを妨げない。微生物菌体を
含む培養液、処理物あるいは、これらの固定化物を用い
る場合には、乾燥菌体のM量に換算してその使用量を決
定すればよい。In addition, it is not prohibited to set it outside this range. When using a culture solution containing microbial cells, a treated product, or an immobilized product thereof, the amount to be used may be determined by converting it to the amount of M of dry microbial cells.
基質であるDL−α−メチルフェニルアラニンアミド類
の使用濃度は、原料として使用したD T、−α−メチ
ルフェニル7957761頭の飽和濃度以下であれば一
般的に制限はないが、好ましくは反応液に対して1wt
’A 以上で、上限は高くとも1 o wt%程度とさ
れる。The concentration of DL-α-methylphenylalanine amide used as a substrate is generally not limited as long as it is below the saturation concentration of 7957761 DT, -α-methylphenyl used as a raw material, but it is preferably added to the reaction solution. 1wt against
'A' or above, the upper limit is set to be about 1 o wt% at most.
本発明では、L−α−メチルフェニルアラニンアミド類
の加水分解反応が、はば終了した時点で可及的速やかに
反応を停止させ、反応生成液から目的物質であるL−α
−メチルフェニルアラニン類と未反志のD−α−メチル
フェニルアラニンアミド類とをそれぞれ分離回収する。In the present invention, when the hydrolysis reaction of L-α-methylphenylalanine amides is completed, the reaction is stopped as soon as possible, and the target substance L-α is extracted from the reaction product liquid.
- Separate and recover methylphenylalanines and unreacted D-α-methylphenylalanine amides.
その分離は、分別晶析、溶媒抽出などの操作で容易に行
なうことができる。The separation can be easily carried out by operations such as fractional crystallization and solvent extraction.
なお、前記の不斉加水分解の操作において、基質中のD
−α−メチルフェニルアラニンアミド類は、菌体処理物
または固定化物により作用を受けないが、反応時間が著
しく長くなると、菌体などの作用を受け、D−α−メチ
ルフェニルアラニン類を生成することがあるので% T
j−α−メチルフェニルアラニンアミド類の加水分解が
終了した時点で反応を可及的速やかに停止させ、D−α
−メチルフェニルアラニン類を多らD−α−メチルフェ
ニルアラニン類を除去する反応生成液のp)(を変化さ
せるおよび/または反応生成液の温度を変化させるなど
の常法による。In addition, in the above-mentioned asymmetric hydrolysis operation, D in the substrate
-α-Methylphenylalanine amides are not affected by bacterial cell-treated products or immobilized products, but if the reaction time is significantly prolonged, they may be affected by bacterial cells and produce D-α-methylphenylalanine. Because there is %T
When the hydrolysis of j-α-methylphenylalanine amides is completed, the reaction is stopped as soon as possible, and D-α
- A large amount of methylphenylalanine is removed by a conventional method such as changing p) of the reaction product solution and/or changing the temperature of the reaction product solution to remove α-methylphenylalanine.
また未反応のD−α−メチルフェニルアラニンアミド類
をたとえば加熱などによりラセミ化して基質として再び
使用することができる。Further, unreacted D-α-methylphenylalanine amide can be racemized, for example, by heating, and used again as a substrate.
実施例によって本発明をさらに具体的に説明する。 The present invention will be explained in more detail with reference to Examples.
実施例 1 グリセロール 50g、コーン・スチーブ。Example 1 Glycerol 50g, corn stew.
リ カー 50 g、 (NH4)2804
5 g、 MIZSO4−7H200,2g、Fe
SO41H200、o s ji。Liquor 50 g, (NH4)2804
5 g, MIZSO4-7H200, 2 g, Fe
SO41H200, o s ji.
CaCl2−2H200、02ji、Mn(j! 2
・4H202m9、NaMoO4・2)T2O1即、N
aCρ 1肩りを純水1fに溶解し、p)Tを7.0V
こ7i!II整した培地100r〆を11容三角フラス
コに(れ、1Kq/r汀2Gで20分間殺面した培地に
、同培地で前培養したミコバクテリウム メタ/リカの
各菌株の培養液を1mlずつ槽菌し、′50℃で65時
間振とう培養を行ない、培養液を1800Orpm で
10分間遠心分離し、菌体を得た。CaCl2-2H200,02ji,Mn(j!2
・4H202m9, NaMoO4・2) T2O1 immediately, N
Dissolve aCρ 1 shoulder in 1f of pure water, and set p)T to 7.0V.
Ko7i! Transfer 100 liters of the prepared medium into an 11-volume Erlenmeyer flask (100 liters) and add 1 ml of the culture solution of each strain of Mycobacterium meta/rica precultured in the same medium to the medium that has been killed at 1 Kq/r for 20 minutes at 2 G. The cells were grown in a tank, cultured with shaking at 50°C for 65 hours, and the culture solution was centrifuged at 1800 rpm for 10 minutes to obtain bacterial cells.
DL−5,4−メチレンジオキシ−α−メチルフェニル
アラニンアミドを2.5g含む純水100+n/に、前
記の菌体を乾燥菌体重量換算で1.25g加え% pH
を9に調整したのち、40°Cで2時間振とうしつ!反
応を行なった。反応終了後、反応生成液を18000r
pmで10分間遠心し、上澄液を得た。この上澄液を高
速液体クロマトグラフィで分析し、生成したL−3,4
−メチレンジオキシ−α−メチルフェニルアラニンの収
率な求め、また、上澄液中のD−3,4−メチレンジオ
キシ−α−メチルフェニルアラニンの定量も行なった。1.25 g of the above-mentioned bacterial cells (calculated as dry bacterial weight) was added to 100+n/ of pure water containing 2.5 g of DL-5,4-methylenedioxy-α-methylphenylalaninamide (% pH).
After adjusting the temperature to 9, shake at 40°C for 2 hours! The reaction was carried out. After the reaction is completed, the reaction product liquid is heated to 18,000 r.
The mixture was centrifuged at pm for 10 minutes to obtain a supernatant. This supernatant liquid was analyzed by high performance liquid chromatography, and the produced L-3,4
The yield of -methylenedioxy-α-methylphenylalanine was determined, and the amount of D-3,4-methylenedioxy-α-methylphenylalanine in the supernatant was also determined.
なお、得られたT、−3,4−メチレンジオキシ−α−
メチルフェニルアラニンの比旋光度を測定したところ、
〔α〕 麿+21.5〜22.5°であった。Note that the obtained T, -3,4-methylenedioxy-α-
When the specific optical rotation of methylphenylalanine was measured,
[α] Maro was +21.5 to 22.5°.
結果を表1に示す。The results are shown in Table 1.
表1
電 基質中に含まれているL3.4−メ千レンジオキ
シーα−メチルフェニルアラニンアミドに対する収率(
以下の実施例でもこれに準する)。Table 1 Yield for L3.4-methylenedioxy-α-methylphenylalanine amide contained in the substrate (
This also applies to the following examples).
栗秦 生成された3、4−メチレンジオキシ−α−メチ
ルフェニルアラニンの丁1*トD体のモル比。たyし、
分母は9体を示す(以下の実施例でもこれに準する)。Kurihata Molar ratio of the D-1*-D form of 3,4-methylenedioxy-α-methylphenylalanine produced. However,
The denominator indicates 9 bodies (this also applies to the following examples).
実施例 2
T)T、−3,4−メチレンジオキシ−α−メ千1と同
様に行なったっ
結果を表2に示す。Example 2 T) T, -3,4-methylenedioxy-α-methylene 1 The results are shown in Table 2.
表2
実施例 3
DL−5,4−メチレンジオキシ−α−メチルフェニル
アラニンアミドを2.59含む純水に、菌体な乾燥菌体
重量換算で0.251!加え、つた。Table 2 Example 3 In pure water containing 2.59 DL-5,4-methylenedioxy-α-methylphenylalaninamide, 0.251 in terms of dry bacterial weight! In addition, ivy.
結果を表3に示す。The results are shown in Table 3.
表3
実施例 4
グルコース 10g、ポリペプトン 5g、酵母エキス
5g、KT(2PO419、ML2SO4・7H20
0、4fl、FeSO47H200,03g、MnCl
2・4T(200,03,j9. T)T、−り 、
4−メ千レンジオキシーα−メチルフェニルアラニンア
ミド 5Iを純水1/r−溶解し、pHを7.0に調整
した培地1oomeを1a容□三角フラスコに入れ、I
K9/Crn2 Gで20分間殺菌した培地に、同培
地で前培養したミコバクテリウム メタノリカ P−2
3の培養液をj ml植菌し、30℃で65時間培養を
行ない、この培養液を18000rpm で10分間遠
心分離し、菌体な得た。Table 3 Example 4 Glucose 10g, polypeptone 5g, yeast extract 5g, KT (2PO419, ML2SO4・7H20
0.4fl, FeSO47H200.03g, MnCl
2・4T(200,03,j9.T)T,-ri,
4-Methylenedioxy-α-methylphenylalaninamide 5I was dissolved in pure water at 1/r and 1 oome of a medium with the pH adjusted to 7.0 was placed in a 1a volume □ Erlenmeyer flask, and I
Mycobacterium methanolica P-2 precultured in a medium sterilized with K9/Crn2 G for 20 minutes.
J ml of the culture solution from No. 3 was inoculated and cultured at 30°C for 65 hours. This culture solution was centrifuged at 18,000 rpm for 10 minutes to obtain bacterial cells.
DL−3,4−メチレンジオキシ−α−メチルフェニル
アラニンアミドを2.5g含む補水100m/に、前記
の菌体な乾燥菌体重量換算で1.25J加え、pHを9
に調整したのち、40℃で48時間振とりしつ〜反応を
行なった。。To 100 m/100 m of supplementary water containing 2.5 g of DL-3,4-methylenedioxy-α-methylphenylalanine amide, 1.25 J (calculated as dry bacterial weight) of the above bacteria was added, and the pH was adjusted to 9.
After adjusting the temperature, the mixture was shaken and reacted at 40° C. for 48 hours. .
反応終了後、反応生成液を1800Orpm で10
分間遠心分離し、上澄液を得た。この上澄液を高速液体
クロマトグラフィで分析したところ、基質中の5体アミ
ドに対してL−1,4−メチレンジオキシ−α−メチル
フェニルアラニンが98壬生成されていた。また、D−
3,4−メチレンシオキシーα−メチルフェニルアラニ
ンはL−3,4−メチレンジオキシ−α−メチルフェニ
ルアラニンに対して0.4モル嶋であった。After the reaction is completed, the reaction product solution is heated at 1800 rpm for 10
Centrifugation was performed for a minute to obtain a supernatant. When this supernatant was analyzed by high performance liquid chromatography, it was found that 98 units of L-1,4-methylenedioxy-α-methylphenylalanine were produced relative to the 5-amide amide in the substrate. Also, D-
The amount of 3,4-methylenedioxy-α-methylphenylalanine was 0.4 molar relative to L-3,4-methylenedioxy-α-methylphenylalanine.
実施例 5
メタノール 10.9%KH2PO41,4,li+
。Example 5 Methanol 10.9%KH2PO41,4,li+
.
(NH4’rz80439.NazHPO42,1g、
Mg804−7H200,2,9、FeC6H5O丁・
xT(2030j19、CaC/2・2H2050’l
t?、ZnFi047H205119、MnC/14H
20511G’、Cu804・5H20Q、5b7を純
水11に溶解し、pHを7.1に調整した培地200
+q/を1/!容三角フラスコに入れ、IKf/m2Q
で20分間殺菌した培地に、同培地で前培養したミコバ
クテリウム メタノリカ P−23の培養液を1阿C植
菌し、30°Cで4日間培養を行ない、培養液を180
0Orpm で10分間遠心分離し、菌体な得た。(NH4'rz80439.NazHPO42, 1g,
Mg804-7H200,2,9, FeC6H50-
xT (2030j19, CaC/2・2H2050'l
T? , ZnFi047H205119, MnC/14H
Medium 200 in which 20511G', Cu804・5H20Q, and 5b7 were dissolved in 11 parts of pure water and the pH was adjusted to 7.1.
+q/ to 1/! Pour into Erlenmeyer flask, IKf/m2Q
A culture of Mycobacterium methanolica P-23 pre-cultured in the same medium was inoculated into a medium that had been sterilized for 20 minutes at 30°C, and cultured at 30°C for 4 days.
The cells were centrifuged at 0 rpm for 10 minutes to obtain bacterial cells.
DL−3,4−メチレンジオキシ−α−メチルフェニル
アラニンアミドを2.5g含む純水1o o ml;に
前記の菌体な乾燥重量換算で0.259加え、pT(を
9に調整したのち、40℃で48時間振とうしつ〜反応
を行なった。反応終了後、反応生成液を1800Orp
m で10分間遠心分離し、上澄液を得た。この上澄
液な高速液体クロマトグラフィで分析したところ、基質
中の5体アミドに対し、L−3,4−メチレンジオキシ
−α−メチルフェニルアラニンが63チ生成されていた
。また、D−3,4−ジメトキシ−α−メチルフェニル
アラニンは、L−3,4−メチレンジオキシ−α−メチ
ルフェニルアラニンに対して0.3モルチであった。To 100 ml of pure water containing 2.5 g of DL-3,4-methylenedioxy-α-methylphenylalaninamide was added 0.259 in terms of the dry weight of the bacterial cells, and the pT was adjusted to 9. The reaction was carried out by shaking at 40°C for 48 hours. After the reaction was completed, the reaction product solution was heated at 1800 Orp.
The supernatant was obtained by centrifugation at m for 10 minutes. When this supernatant was analyzed by high performance liquid chromatography, it was found that 63 units of L-3,4-methylenedioxy-α-methylphenylalanine were produced with respect to the 5-amide amide in the substrate. Moreover, D-3,4-dimethoxy-α-methylphenylalanine was 0.3 molti with respect to L-3,4-methylenedioxy-α-methylphenylalanine.
実施例 6
実施例1と同様にして、ミコバクテリウムメタノリカ
BT−F3aの培養を行なって菌体を得た。Example 6 In the same manner as in Example 1, Mycobacterium methanolica
BT-F3a was cultured to obtain bacterial cells.
この菌体を使用して、基質としてDI、−3゜4−ジヒ
ドロキシ−α−メチルフェニルアラニンアミド、DL−
4−ヒドロキシ−3−メトキシ−α−メチルフェニルア
ラニンアミドおよびDL−5,4−ジメトキシ−α−メ
チルフェニルアラニンアミドをそれぞれ用い、反応時間
を24時間とした以外は実施例1と同様に反応を行なっ
た。結果を表4に示す。Using this bacterial cell, DI, -3゜4-dihydroxy-α-methylphenylalaninamide, DL-
The reaction was carried out in the same manner as in Example 1, except that 4-hydroxy-3-methoxy-α-methylphenylalaninamide and DL-5,4-dimethoxy-α-methylphenylalaninamide were used, and the reaction time was 24 hours. . The results are shown in Table 4.
本発明によれば、医薬品として使用されている、たとえ
ばL−α−メチルドーパのようなL−α−メチルフェニ
ルアラニン類を容易に、かつ、安定的に、しかも効率よ
く得ることが可能となる。According to the present invention, L-α-methylphenylalanines such as L-α-methyldopa, which are used as pharmaceuticals, can be easily, stably, and efficiently obtained.
特許出願人 三菱瓦斯化学株式会社 代表者長野和吉Patent applicant: Mitsubishi Gas Chemical Co., Ltd. Representative Kazuyoshi Nagano
Claims (1)
て、水素原子、低級アルキル基であるかまたは、R^1
とR^2はともにアルキレン基であつて互いに結合し、
5〜8員環を形成することもできる。) で表わされるDL−α−メチルフェニルアラニンアミド
類に、ミコバクテリウムメタノリカの菌体またはその処
理物を作用させてL−α−メチルフェニルアラニンアミ
ド類を不斉加水分解して、 一般式II ▲数式、化学式、表等があります▼ (ただし、式中R^1およびR^2は前記一般式 I に
おけると同様である。) で表わされるL−α−メチルフェニルアラニン類を得る
ことを特徴とするL−α−メチルフェニルアラニン類の
製造法。[Claims] General formula I ▲ Numerical formulas, chemical formulas, tables, etc.▼ (However, in the formula, R^1 and R^2 are the same or different and are a hydrogen atom, a lower alkyl group, or R^1
and R^2 are both alkylene groups and bond to each other,
A 5- to 8-membered ring can also be formed. ) DL-α-methylphenylalanine amides represented by the formula II are asymmetrically hydrolyzed by the action of Mycobacterium methanolica cells or their treated products, resulting in general formula II ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (However, R^1 and R^2 in the formula are the same as in the above general formula I.) It is characterized by obtaining L-α-methylphenylalanine represented by Method for producing L-α-methylphenylalanines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26676086A JPS63123398A (en) | 1986-11-11 | 1986-11-11 | Production of l-alpha-methylphenylalanines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26676086A JPS63123398A (en) | 1986-11-11 | 1986-11-11 | Production of l-alpha-methylphenylalanines |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63123398A true JPS63123398A (en) | 1988-05-27 |
Family
ID=17435329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26676086A Pending JPS63123398A (en) | 1986-11-11 | 1986-11-11 | Production of l-alpha-methylphenylalanines |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63123398A (en) |
-
1986
- 1986-11-11 JP JP26676086A patent/JPS63123398A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5886093A (en) | Biological preparation of amide | |
JPS6156086A (en) | Microbial preparation of alpha-hydroxyacid and its salt | |
JP3951008B2 (en) | Capsaicin decomposing / synthesizing enzyme and production method thereof | |
US4357425A (en) | Process for producing L-amino acid oxidase | |
JPS63123398A (en) | Production of l-alpha-methylphenylalanines | |
JPS58201985A (en) | Production of glucose dehydrogenase | |
JPH0155879B2 (en) | ||
US5496715A (en) | Process for preparing indigo | |
JP2936552B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
JPH02227069A (en) | Culture of bacteria | |
JPH02100674A (en) | Culture of bacterium | |
JPH01108988A (en) | Production of pyroracemic acid | |
JPS589672B2 (en) | Biseibutsunobayouhouhou | |
SU644833A1 (en) | 85 escherichia coli strain as producer of l-aspartic acid | |
JPS6319158B2 (en) | ||
JP3233878B2 (en) | Method for producing L-aspartic acid | |
JP3011472B2 (en) | Production method of indigo by enzymatic method | |
JPS6269993A (en) | Production of optically active alpha-monochlorohydrin by bacterium treatment | |
JPS63157990A (en) | Production of l-alpha-methylphenylalanines | |
JP2901458B2 (en) | Method for producing gentianose | |
KR930008972B1 (en) | New microorganism pseudomonas sp. y-132 and preparation of glutaryl 1-7-amino cephalosporanic acid acyase | |
SU1523569A1 (en) | Strain of citrobacter freundii bacteria for biotransformation of fumarate to l-malic acid | |
JPH0424992B2 (en) | ||
JPH0362397B2 (en) | ||
JPS63129988A (en) | Production of trans-4-cyanocyclohexane-1-carboxylic acid |